Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation.
| Image |  |
|---|---|
| Description | scientific article published on 11 May 2015 |
| Author/s |
author: Seok-Goo Cho |
| Publication date | May 11, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |